lassa/ebola vaccine (Zalgen/Tulane/TSRI/Burnham)

N/A

Report date: 2025/01/26 15:55:03

Base Information

Drug Namelassa/ebola vaccine (Zalgen/Tulane/TSRI/Burnham)
Drug Alias NameN/A
ClassificationVaccines
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHemorrhagic Fever, EbolaLassa Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZalgen Labs LLC
China Registration ClassN/A

Develop Information

Active CompaniesZalgen Labs LLCUniversity Of Texas Medical BranchThe Scripps Research Institute Inc +[4] 
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever, EbolaLassa Fever
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A